These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38427065)

  • 1. Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data.
    Lau C; Mohmaed Ali MI; Lin L; van Balen DEM; Jacobs BAW; Nuijen B; Smeenk RM; Steeghs N; Huitema ADR
    Cancer Chemother Pharmacol; 2024 Jul; 94(1):25-34. PubMed ID: 38427065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.
    Darwich AS; Henderson K; Burgin A; Ward N; Whittam J; Ammori BJ; Ashcroft DM; Rostami-Hodjegan A
    Br J Clin Pharmacol; 2012 Nov; 74(5):774-87. PubMed ID: 22463107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study.
    Groenland SL; van Eerden RAG; Verheijen RB; Koolen SLW; Moes DJAR; Desar IME; Reyners AKL; Gelderblom HJ; van Erp NP; Mathijssen RHJ; Huitema ADR; Steeghs N
    Ther Drug Monit; 2019 Oct; 41(5):561-567. PubMed ID: 31568233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of oral targeted antineoplastic drugs.
    Mueller-Schoell A; Groenland SL; Scherf-Clavel O; van Dyk M; Huisinga W; Michelet R; Jaehde U; Steeghs N; Huitema ADR; Kloft C
    Eur J Clin Pharmacol; 2021 Apr; 77(4):441-464. PubMed ID: 33165648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of Orally Administered Drugs After Bariatric Surgery.
    Dvořáčková E; Pilková A; Matoulek M; Slanař O; Hartinger JM
    Curr Obes Rep; 2024 Mar; 13(1):141-153. PubMed ID: 38172482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes.
    Giraud EL; Westerdijk K; van der Kleij MBA; Guchelaar NAD; Meertens M; Bleckman RF; Rieborn A; Mohammadi M; Roets E; Mathijssen RHJ; Huitema ADR; Koolen SLW; Gelderblom H; Moes DJAR; Reyners AKL; Touw DJ; Keizer-Heldens P; Oosten AW; van der Graaf WTA; Steeghs N; van Erp NP; Desar IME;
    ESMO Open; 2024 Jun; 9(6):103477. PubMed ID: 38833964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
    Marquet P; Rousseau A
    Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in Oncology.
    Groenland SL; van Nuland M; Verheijen RB; Schellens JHM; Beijnen JH; Huitema ADR; Steeghs N
    Clin Pharmacokinet; 2019 Mar; 58(3):299-308. PubMed ID: 29862467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs.
    Cardoso E; Csajka C; Schneider MP; Widmer N
    Clin Pharmacokinet; 2018 Jan; 57(1):1-6. PubMed ID: 28634655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.
    Gotta V; Widmer N; Decosterd LA; Chalandon Y; Heim D; Gregor M; Benz R; Leoncini-Franscini L; Baerlocher GM; Duchosal MA; Csajka C; Buclin T
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1307-19. PubMed ID: 25297989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.
    Rousseau A; Marquet P
    Fundam Clin Pharmacol; 2002 Aug; 16(4):253-62. PubMed ID: 12570013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Personalized medicine for oral molecular-targeted anticancer drugs].
    Miura M
    Nihon Yakurigaku Zasshi; 2019; 153(2):73-78. PubMed ID: 30745517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Extrapolation Methods to Predict Trough Concentrations to Guide Therapeutic Drug Monitoring of Oral Anticancer Drugs.
    Janssen JM; Dorlo TPC; Beijnen JH; Huitema ADR
    Ther Drug Monit; 2020 Aug; 42(4):532-539. PubMed ID: 32384536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
    Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
    Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology.
    Erku D; Schneider J; Scuffham P
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00862. PubMed ID: 34546005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.
    Widmer N; Bardin C; Chatelut E; Paci A; Beijnen J; Levêque D; Veal G; Astier A
    Eur J Cancer; 2014 Aug; 50(12):2020-36. PubMed ID: 24928190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance.
    Martin KA; Lee CR; Farrell TM; Moll S
    Am J Med; 2017 May; 130(5):517-524. PubMed ID: 28159600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
    Groenland SL; Mathijssen RHJ; Beijnen JH; Huitema ADR; Steeghs N
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1309-1318. PubMed ID: 31175385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
    Marquet P
    Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.